Skip to content

SUBSCRIBER ONLY

Health |
Safety of generic Viagra, other drugs called into doubt after false data found by FDA

The U.S. Food and Drug Administration alerted brand-name and generic companies in June about a research company in India that had falsified the data used in key studies to gain approval of its medications. Data from the researcher, Synapse Labs Pvt. Ltd., may have been used in hundreds of drugs, which remain available for sale on pharmacy shelves and in Americans’ medicine cabinets. (Dreamstime/TNS)
The U.S. Food and Drug Administration alerted brand-name and generic companies in June about a research company in India that had falsified the data used in key studies to gain approval of its medications. Data from the researcher, Synapse Labs Pvt. Ltd., may have been used in hundreds of drugs, which remain available for sale on pharmacy shelves and in Americans’ medicine cabinets. (Dreamstime/TNS)
UPDATED:

The U.S. Food and Drug Administration alerted brand-name and generic companies June 18 about a research company in India that had falsified the data used in key studies to gain approval of its medications.

Subscribe to continue reading this article.

Already subscribed? To login in, click here.

Originally Published: